Phase transitions of antibiotic clarithromycin forms I, IV and new form VII crystals

Int J Pharm. 2018 Aug 25;547(1-2):258-264. doi: 10.1016/j.ijpharm.2018.05.073. Epub 2018 Jun 1.

Abstract

Metastable crystal form I of the antibiotic clarithromycin has a pharmaceutically valuable characteristic that its crystalline phase transition can be applied for its sustained release from tablets. The phase transition of form I was investigated in detail by single crystal and powder X-ray analyses, dynamic vapor sorption analysis and thermal analysis. The single crystal structure of form I revealed that form I was not an anhydrate crystal but contained a partially occupied water molecule in the channel-like void space. Dynamic vapor sorption (DVS) analysis demonstrated that form I crystals reversibly sorbed water molecules in two steps when the relative humidity (RH) increased and finally transited to hydrate form IV at 95% RH. DVS analysis also showed that when the RH decreased form IV crystals lost water molecules at 40% RH and transited to the newly identified anhydrate crystal form VII. Form VII reversibly transited to form IV at lower RH than form I, suggesting that form I is more suitable for manufacturing a sustained-release tablet of CAM utilizing the crystalline phase transition.

Keywords: Antibiotic; Clarithromycin; Crystalline phase transition; Dynamic vapor sorption analysis; Single crystal X-ray crystallography; Thermal analysis.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Chemistry, Pharmaceutical / methods*
  • Clarithromycin / chemistry*
  • Crystallization
  • Delayed-Action Preparations
  • Humidity
  • Phase Transition
  • Tablets
  • Water / chemistry*
  • X-Ray Diffraction

Substances

  • Anti-Bacterial Agents
  • Delayed-Action Preparations
  • Tablets
  • Water
  • Clarithromycin